Insider transactions

EDGAR

Alaunos Therapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-16.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–21 of 21

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-06 Filed 2026-10-08Vieser Jaime Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)22,6690.7444
16,874.8036

Derived: shares × price per share. Exact value 16874.8036.

70,311Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of board fees.
Open filing 0001193125-26-417971 Read from the filing’s XML Dispute this row
2026-10-06 Filed 2026-10-08Jerman Michael Allen Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)20,9900.7444
15,624.956

Derived: shares × price per share. Exact value 15624.9560.

44,749Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of board fees.
Open filing 0001193125-26-417974 Read from the filing’s XML Dispute this row
2026-10-06 Filed 2026-10-08Postma Robert W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)21,8290.7444
16,249.5076

Derived: shares × price per share. Exact value 16249.5076.

80,438Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of board fees.
Open filing 0001193125-26-417969 Read from the filing’s XML Dispute this row
2026-10-06 Filed 2026-10-08Weis Holger Officer: CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)23,5640.7444
17,541.0416

Derived: shares × price per share. Exact value 17541.0416.

49,047Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of net salary.
Open filing 0001193125-26-417970 Read from the filing’s XML Dispute this row
2026-08-06 Filed 2026-08-11Weis Holger Officer: CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,3632.01
8,769.63

Derived: shares × price per share. Exact value 8769.63.

25,483Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of net salary.
Open filing 0001193125-26-344682 Read from the filing’s XML Dispute this row
2026-07-23 Filed 2026-07-27Vieser Jaime Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8,7891.92
16,874.88

Derived: shares × price per share. Exact value 16874.88.

47,642Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of board fees.
Open filing 0001193125-26-318100 Read from the filing’s XML Dispute this row
2026-07-23 Filed 2026-07-27Postma Robert W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8,4631.92
16,248.96

Derived: shares × price per share. Exact value 16248.96.

58,609Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of board fees.
Open filing 0001193125-26-318103 Read from the filing’s XML Dispute this row
2026-07-23 Filed 2026-07-27Weis Holger Officer: CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,5681.92
8,770.56

Derived: shares × price per share. Exact value 8770.56.

21,120Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of net salary.
Open filing 0001193125-26-318105 Read from the filing’s XML Dispute this row
2026-07-23 Filed 2026-07-27Jerman Michael Allen Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8,1381.92
15,624.96

Derived: shares × price per share. Exact value 15624.96.

23,759Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of board fees.
Open filing 0001193125-26-318114 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Weis Holger Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)3,8802.26
8,768.8

Derived: shares × price per share. Exact value 8768.80.

16,552Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of net salary.
Open filing 0001193125-26-295004 Read from the filing’s XML Dispute this row
2026-06-12 Filed 2026-06-17Weis Holger Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)7,7612.26
17,539.86

Derived: shares × price per share. Exact value 17539.86.

12,672Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of net salary.
Open filing 0001193125-26-274305 Read from the filing’s XML Dispute this row
2026-05-22 Filed 2026-05-27Weis Holger Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)3,7002.37
8,769

Derived: shares × price per share. Exact value 8769.00.

4,911Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of net salary.
Open filing 0001193125-26-241999 Read from the filing’s XML Dispute this row
2026-04-29 Filed 2026-05-01Vieser Jaime Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6,5152.59
16,873.85

Derived: shares × price per share. Exact value 16873.85.

38,853Direct (D) No— Open filing 0001193125-26-201557 Read from the filing’s XML Dispute this row
2026-04-29 Filed 2026-05-01Jerman Michael Allen Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6,0322.59
15,622.88

Derived: shares × price per share. Exact value 15622.88.

15,621Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of board fees.
Open filing 0001193125-26-201474 Read from the filing’s XML Dispute this row
2026-04-29 Filed 2026-05-01Postma Robert W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6,2742.59
16,249.66

Derived: shares × price per share. Exact value 16249.66.

50,146Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of board fees.
Open filing 0001193125-26-201489 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-15Vieser Jaime Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,8392.89
16,874.71

Derived: shares × price per share. Exact value 16874.71.

32,338Direct (D) No— Open filing 0001193125-26-014115 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-15Jerman Michael Allen Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,4062.89
15,623.34

Derived: shares × price per share. Exact value 15623.34.

9,589Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of board fees.
Open filing 0001193125-26-014117 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-15Postma Robert W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,6222.89
16,247.58

Derived: shares × price per share. Exact value 16247.58.

43,872Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of board fees.
Open filing 0001193125-26-014116 Read from the filing’s XML Dispute this row
2025-11-21 Filed 2025-11-26Postma Robert W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,1423.16
16,248.72

Derived: shares × price per share. Exact value 16248.72.

38,250Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of board fees.
Open filing 0001193125-25-301026 Read from the filing’s XML Dispute this row
2025-11-21 Filed 2025-11-26Jerman Michael Allen Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,1833.16
13,218.28

Derived: shares × price per share. Exact value 13218.28.

4,183Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of board fees.
Open filing 0001193125-25-301025 Read from the filing’s XML Dispute this row
2025-11-21 Filed 2025-11-26Vieser Jaime Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,3403.16
16,874.4

Derived: shares × price per share. Exact value 16874.40.

26,499Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of board fees.
Open filing 0001193125-25-301033 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 7,211 filings read, the latest filed 2026-11-13. Prior quarter ending 2026-06-30: 9,150 filings read.

Showing 1–24 of 24

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BlackRock, Inc. Partly reported under another manager21,353 SH18,951 dollarsUnchanged Prior quarter: 21,353Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager19,291 SH16,964 dollarsLower by 65 Prior quarter: 19,356Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
VANGUARD FIDUCIARY TRUST CO 15,497 SH13,622 dollarsUnchanged Prior quarter: 15,497Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 14,063 SH12,361 dollarsUnchanged Prior quarter: 14,063Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
OSAIC HOLDINGS, INC. Partly reported under another manager1,665 SH1,592 dollarsLower by 66 Prior quarter: 1,731Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row
JONES FINANCIAL COMPANIES LLLP Partly reported under another manager1,330 SH1,450 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-459442 Filed 2026-11-13 Dispute this row
Arax Advisory Partners Partly reported under another manager1,216 SH1,080 dollarsUnchanged Prior quarter: 1,216Open filing 0001586767-26-000009 Filed 2026-11-12 Dispute this row
MORGAN STANLEY Partly reported under another manager1,196 SH1,061 dollarsHigher by 360 Prior quarter: 836Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Vanguard Global Advisers, LLC 501 SH440 dollarsUnchanged Prior quarter: 501Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row
EverSource Wealth Advisors, LLC 135 SH120 dollarsNot in the prior quarter’s filings read Open filing 0001710537-26-000009 Filed 2026-11-04 Dispute this row
Steward Partners Investment Advisory, LLC 112 SH99 dollarsUnchanged Prior quarter: 112Open filing 0001723397-26-000006 Filed 2026-11-13 Dispute this row
UBS Group AG Partly reported under another manager67 SH60 dollarsLower by 925 Prior quarter: 992Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
BOKF, NA Partly reported under another manager66 SH59 dollarsUnchanged Prior quarter: 66Open filing 0000009634-26-000005 Filed 2026-10-27 Dispute this row
Key Financial Inc 24 SH21 dollarsUnchanged Prior quarter: 24Open filing 0001420506-26-002442 Filed 2026-11-02 Dispute this row
SIGNATUREFD, LLC 23 SH20 dollarsUnchanged Prior quarter: 23Open filing 0001456048-26-000007 Filed 2026-10-23 Dispute this row
NFSG Corp Partly reported under another manager21 SH19 dollarsUnchanged Prior quarter: 21Open filing 0001879757-26-000009 Filed 2026-10-15 Dispute this row
LANARK FINANCIAL, INC. 20 SH18 dollarsUnchanged Prior quarter: 20Open filing 0000791540-26-000020 Filed 2026-10-26 Dispute this row
WEST PACES ADVISORS INC. 10 SH9 dollarsUnchanged Prior quarter: 10Open filing 0001398344-26-018131 Filed 2026-10-13 Dispute this row
Inspire Investing, LLC 9 SH8 dollarsUnchanged Prior quarter: 9Open filing 0001670139-26-000009 Filed 2026-10-22 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager7 SH7 dollarsNot in the prior quarter’s filings read Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager6 SH5 dollarsUnchanged Prior quarter: 6Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
IFG Advisory, LLC 6 SH5 dollarsUnchanged Prior quarter: 6Open filing 0001728319-26-000008 Filed 2026-11-09 Dispute this row
Caitong International Asset Management Co., Ltd 4 SH4 dollarsNot in the prior quarter’s filings read Open filing 0001628280-26-068135 Filed 2026-10-29 Dispute this row
Tidemark, LLC 2 SH2 dollarsUnchanged Prior quarter: 2Open filing 0002009591-26-000008 Filed 2026-11-09 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • CITADEL ADVISORS LLC 11,870 SH
  • Tower Research Capital LLC (TRC) 1,621 SH
  • WELLS FARGO COMPANY/MN 388 SH
  • ROYAL BANK OF CANADA 375 SH
  • Blue Trust, Inc. 135 SH
  • Federation des caisses Desjardins du Quebec 70 SH
  • Axiom Investment Management LLC 46 SH
  • MERCER GLOBAL ADVISORS INC /ADV 38 SH
  • AdvisorNet Financial, Inc 19 SH
  • BARCLAYS PLC 15 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Fairmount Funds Management LLC Common Stock19.99858,789.0010/13/2026 Filed 2026-10-15SCHEDULE 13DOpen filing 0001683168-26-007898 Dispute this row
Fairmount Healthcare Fund II L.P. Common Stock3.98171,000.0010/13/2026 Filed 2026-10-15SCHEDULE 13DOpen filing 0001683168-26-007898 Dispute this row
Fairmount Healthcare Co-Invest VII L.P. Common Stock19.99858,789.0010/13/2026 Filed 2026-10-15SCHEDULE 13DOpen filing 0001683168-26-007898 Dispute this row
Harwin Peter Evan Common Stock19.99858,789.0010/13/2026 Filed 2026-10-15SCHEDULE 13DOpen filing 0001683168-26-007898 Dispute this row
Kiselak Tomas Common Stock19.99858,789.0010/13/2026 Filed 2026-10-15SCHEDULE 13DOpen filing 0001683168-26-007898 Dispute this row
WaterMill Asset Management Corp. Common Stock, par value $0.001 per share9.99434,229.0010/13/2026 Filed 2026-10-15SCHEDULE 13D/AAmendment 1Open filing 0001193805-26-001370 Dispute this row
Postma Robert W Common Stock, par value $0.001 per share9.99514,691.0010/13/2026 Filed 2026-10-15SCHEDULE 13D/AAmendment 1Open filing 0001193805-26-001370 Dispute this row
Price Adrian Common stock8.6189,061.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Chris Butterworth Common stock0.510,700.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Richard Jones Common stock0.716,000.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Edward Jones Common stock0.511,750.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Gareth Downing Common stock0.919,552.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Richard Kotey Common stock0.612,530.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Chris Cole Common stock0.715,856.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Arif Chaudrey Common stock0.36,423.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Emma Babb Common stock0.510,366.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Colin Craig Common stock0.37,000.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
John Nicholls Common stock0.816,743.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Carl Ware Common stock0.11,721.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Andrew Turner Common stock0.613,035.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Matthew Robbins Common stock0.510,036.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Phillip James Stead Common stock0.511,012.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Stephen Hennessy Common stock0.37,108.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Greg Arnold Common stock0.510,735.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Michelle Douglas Common stock0.48,494.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
HexagonONE Ltd Common stock0.00.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Alimenta Holding Limited Common stock0.00.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Krakatau Holding Limited Common stock0.00.0002/24/2026 Filed 2026-03-05SCHEDULE 13D/AAmendment 4Open filing 0002094682-26-000002 Dispute this row
Price Adrian Common stock8.6189,061.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Chris Butterworth Common stock0.510,700.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Richard Jones Common stock0.716,000.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Edward Jones Common stock0.511,750.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Gareth Downing Common stock0.919,552.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Richard Kotey Common stock0.612,530.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Chris Cole Common stock0.715,856.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Arif Chaudrey Common stock0.36,423.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Emma Babb Common stock0.510,366.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Colin Craig Common stock0.37,000.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
John Nicholls Common stock0.816,743.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Carl Ware Common stock0.11,721.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Andrew Turner Common stock0.613,035.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Matthew Robbins Common stock0.510,036.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Phillip James Stead Common stock0.511,012.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Stephen Hennessy Common stock0.37,108.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Greg Arnold Common stock0.510,735.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Michelle Douglas Common stock0.48,494.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Hexagon ONE Inc Common stock0.00.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Alimenta Holding Inc Common stock0.00.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Krakatau Holding Inc Common stock0.00.0002/24/2026 Filed 2026-02-24SCHEDULE 13D/AAmendment 3Open filing 0002094682-26-000001 Dispute this row
Price Adrian Common stock8.6189,061.0010/30/2025 Filed 2025-12-05SCHEDULE 13D/AAmendment 2Open filing 0002094682-25-000003 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,092,408 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
202240,015
2023199,811
2024185,386
2025235,520
2026254,737

Filings made before the SEC required XML are listed, not extracted.

Back to Alaunos Therapeutics, Inc.